Press Notice

Science and Technology Committee

No. 21 of Session 2002-03

20 March 2003



Wednesday 2 April 4.30 pm

Committee Room 15

Research: Government and Pharmaceutical industry

AT 4.30PM

Mr Nick Higgins

Chief Business Officer, Acambis

Dr Paul Drayson

Chief Executive, PowderJect

Dr Philip Wright,

Director, Science and Technology, Association for the British Pharmaceutical Industry, with

Mr John Keddie

Director, Environmental Health and Safety, GlaxoSmithKline

AT 5.15 PM (Approx)*

Dr David Harper

Chief Scientist, Department of Health

Dr Richard Scott

Director Science, Defence Science and Technology Laboratory

Mr Brian Coleman

Director, Police Scientific Development Branch

* Only the first part of this session will be held in public.

For further information, please ring the Committee staff on 020 7219 2793/4, or refer to the Committee Office Information Line on 020 7219 2033. 

Previous press notices and publications are available on our website C

 Notes for those wishing to attend a public meeting of the Committee

Members of the public wishing to attend should present themselves at St Stephen's Entrance, or Portcullis House if appropriate, where they will be directed through security and to the appropriate Committee Room.  It is advisable to allow about 15 minutes for this. It is possible for the Committee Room designated for the hearing to change at short notice, but such room changes will be clearly  indicated.  Please ensure that mobile phones and pagers are turned off before entering the Committee Room.  Under no circumstances should members of the public address the Committee while in session.  It is not possible for seats to be reserved in the Committee Room but every effort is made to ensure sufficient seating.  Standing in Committee Rooms is permitted at the discretion of the Chairman.  Those attending meetings are asked to remain silent throughout.

Notes for Editors

Under the terms of Standing Order No. 152 the Committee is empowered to examine the "expenditure, policy and administration of the Office of Science and Technology and its associated public bodies". The Committee was appointed on 12 November 2001.

The Committee announced their inquiry into The Scientific Response to Terrorism on 19 December 2002, see Press Notice No. 8 of Session 2002-03.

The first evidence session of evidence was held on 5 March with representatives of  the constituent parts of the new Health Protection Agency,  the BMA, the Royal College of GPs, the British Infection Society and Royal College of Physicians, NHS Trusts and the Ambulance Service.   Future evidence sessions will focus on:

- Controls on research in universities

- Detection technology: emergency services; food, water and transport industries

- Scientific advice and public communication policy

- Government co-ordination of policy

Dates and details of witnesses to be announced.